Erythropoietin protects retinal ganglion cells and visual function after ocular ischemia and optic nerve compression;Erythropoietin schützt retinale Ganglienzellen und die Sehfunktion nach Ischämie und Sehnervkom-pression im Rattenmodell

Ophthalmologe

Volumn 107, Issue 4, 2010, Pages 347-353

  Jehle, T ^a   Meschede, W ^a   Dersch, R ^a   Feltgen, N ^b   Bach, M ^a   Lagreze W A ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

Author keywords

Erythropoietin; Ischemia; Optic nerve compression; Rat; Toxicology

Indexed keywords

ERYTHROPOIETIN;

ANIMAL; ARTICLE; DRUG EFFECT; EVOKED VISUAL RESPONSE; ISCHEMIC OPTIC NEUROPATHY; MALE; OPTIC NERVE INJURY; PATHOPHYSIOLOGY; RAT; TREATMENT OUTCOME; VISUAL DISORDER; COMPLICATION; DRUG EFFECTS; OPTIC NERVE INJURIES; OPTIC NEUROPATHY, ISCHEMIC; VISION DISORDERS;

ANIMALS; ERYTHROPOIETIN; EVOKED POTENTIALS, VISUAL; MALE; OPTIC NERVE INJURIES; OPTIC NEUROPATHY, ISCHEMIC; RATS; TREATMENT OUTCOME; VISION DISORDERS;

EID: 77954033051     PISSN: 0941293X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00347-009-2030-1     Document Type: Article

References (30)

1. Chappell D, Tilbrook PA, Bittorf T et al (1997) Prevention of apoptosis in J2E erythroid cells by erythropoietin: involvement of JAK2 but not MAP kinases. Cell Death Differ 4: 105-113.
2. Diem R, Sattler MB, Merkler D et al (2005) Combined therapy with methylprednisolone and erythropoietin in a model of multiple sclerosis. Brain 128: 375-385.
3. Dureau P, Bonnel S, Menasche M et al (2001) Quantitative analysis of intravitreal injections in the rat. Curr Eye Res 22: 74-77.
4. Grimm C, Wenzel A, Groszer M et al (2002) HIF-1-induced erythropoietin in the hypoxic retina protects against light-induced retinal degeneration. Nat Med 8: 718-724.
5. Grimm C, Wenzel A, Stanescu D et al (2004) Constitutive overexpression of human erythropoietin protects the mouse retina against induced but not inherited retinal degeneration. J Neurosci 24: 5651-5658.
6. Jehle T, Dimitriu C, Auer S et al (2008) The neuropeptide NAP provides neuroprotection against retinal ganglion cell damage after retinal ischemia and optic nerve crush. Graefes Arch Clin Exp Ophthalmol 246: 1255-1263.
7. Jehle T, Ehlken D, Wingert K et al (2009) Influence of narcotics on luminance and frequency modulated visual evoked potentials in rats. Doc Ophthalmol.
8. Jehle T, Kunze D, Wingert K et al (2007) Modulation of Contrast Depth and Flash Frequencies: Effects on Visual Evoked Potentials Recorded in Awake, Freely Moving Brown Norway Rats. Poster Presentation at ARVO's 2007 Annual Meeting, May 6 - May 10, 2007 in Fort Lauderdale, Florida: 3756/B3394.
9. Jehle T, Lagreze WA, Blauth E et al (2000) Gabapentin-lactam (8-aza-spiro[5, 4]decan-9-on; GBP-L) inhibits oxygen glucose deprivation-induced [3H]glutmate release and is a neuroprotective agent in amodel of acute retinal ischemia. Naunyn Schmiedebergs Arch Pharmacol 362: 74-81.
10. Jehle T, Wingert K, Dimitriu C et al (2008) Quantification of ischemic damage in the rat retina: a comparative study using evoked potentials, electroretinography and histology. Invest Ophthalmol Vis Sci 49: 1056-1064.
11. Junk AK, Mammis A, Savitz SI et al (2002) Erythropoietin administration protects retinal neurons from acute ischemia-reperfusion injury. Proc Natl Acad Sci U S A 9910659-10664.
12. Kermer P, Klocker N, Bahr M (1999) Long-term effect of inhibition of ced 3-like caspases on the survival of axotomized retinal ganglion cells in vivo. Exp Neurol 158: 202-205.
13. Kilic U, Kilic E, Soliz J et al (2005) Erythropoietin protects from axotomy-induced degeneration of retinal ganglion cells by activating ERK-1/-2. FASEB J 19: 249-251.
14. King CE, Rodger J, Bartlett C et al (2007) Erythropoietin is both neuroprotective and neuroregenerative following optic nerve transection. Exp Neurol 205: 48-55.
15. Klocker N, Cellerino A, Bahr M (1998) Free radical scavenging and inhibition of nitric oxide synthase potentiates the neurotrophic effects of brain-derived neurotrophic factor on axotomized retinal ganglion cells In vivo. J Neurosci 18: 1038-1046.
16. Lafuente MP, Villegas-Perez MP, Mayor S et al (2002) Neuroprotective effects of brimonidine against transient ischemia-induced retinal ganglion cell death: a dose response in vivo study. Exp Eye Res 74: 181-189.
17. Lagreze WA, Feltgen N, Bach M et al (2009) Feasibility of intravitreal erythropoietin injections in humans. Br J Ophthal, angenommen.
18. Lagreze WA, Knorle R, Bach M et al (1998) Memantine is neuroprotective in a rat model of pressure-induced retinal ischemia. Invest Ophthalmol Vis Sci 39: 1063-1066.
19. Rex TS, Allocca M, Domenici L et al (2004) Systemic but not intraocular Epo gene transfer protects the retina from light-and genetic-induced degeneration. Mol Ther 10: 855-861.
20. Sattler MB, Merkler D, Maier K et al (2004) Neuroprotective effects and intracellular signaling pathways of erythropoietin in a rat model of multiple sclerosis. Cell Death Differ 11(Suppl 2): S181-S192.
21. Song BJ, Cai H, Tsai JC et al (2008) Intravitreal recombinant human erythropoietin: a safety study in rabbits. Curr Eye Res 33: 750-760.
22. Tsai JC (2008) Safety of intravitreally administered recombinant erythropoietin (an AOS thesis). Trans Am Ophthalmol Soc 106: 459-472.
23. Tsai JC, Wu L, Worgul B et al (2005) Intravitreal administration of erythropoietin and preservation of retinal ganglion cells in an experimental rat model of glaucoma. Curr Eye Res 30: 1025-1031.
24. Wang J, Hu H, Lu Y et al (2005) The effects of recombinant human erythropoietin on electroretinogram after raising intraocular pressure in rabbits. Yan Ke Xue Bao 21: 161-164.
25. Weishaupt JH, Rohde G, Polking E et al (2004) Effect of erythropoietin axotomy-induced apoptosis in rat retinal ganglion cells. Invest Ophthalmol Vis Sci 45: 1514-1522.
26. Zhang J, Wu Y, Jin Y et al (2008) Intravitreal injection of erythropoietin protects both retinal vascular and neuronal cells in early diabetes. Invest Ophthalmol Vis Sci 49: 732-742.
27. Zhang JF, Wu Yl, Xu JY et al (2008) Pharmacokinetic and toxicity study of intravitreal erythropoietin in rabbits. Acta Pharmacol Sin 29: 1383-1390.
28. Zhang W, Sun B, Yu Z et al (2009) High dose erythropoietin promotes functional recovery of rats following facial nerve crush. J Clin Neurosci 16: 554-556.
29. Zhong L, Bradley J, Schubert W et al (2007) Erythropoietin promotes survival of retinal ganglion cells in DBA/2J glaucoma mice. Invest Ophthalmol Vis Sci 48: 1212-1218.
30. Zhong YS, Liu XH, Cheng Y et al (2008) Erythropoietin with retrobulbar administration protects retinal ganglion cells from acute elevated intraocular pressure in rats. J Ocul Pharmacol Ther 24: 453-459.